Autolus Therapeutics (AUTL) Misses Q3 EPS by 10c

Autolus Therapeutics (NASDAQ: AUTL) reported Q3 EPS of ($0.31), $0.10 worse than the analyst estimate of ($0.21).

For earnings history and earnings-related data on Autolus Therapeutics (AUTL) click here.

You May Also Be Interested In

• Nscale targets up to $3B in US IPO as soon as September - Bloomberg
• MGE Energy (MGEE) Declares $0.5083 Quarterly Dividend; 2.6% Yield
• Ubiquiti (UI) Tops Q4 EPS by 25c, Beats on Revenue